Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Bellevue Group AG
Form 13F · Q2 2026

Bellevue Group AG

CIK 1674546申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$47.5亿
申報組合市值
164
持倉數量
12
Quarters on record
Top 50
持倉數量

Bellevue Group AG——持倉

共 164 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1AMGN Amgen Inc851,550+188.3%$3.1亿6.5%
2VRTX Vertex Pharmaceuticals Inc578,634−15.1%$2.9亿6.0%
3ARGX Argenx Se301,000−3.8%$2.8亿5.9%
4GILD Gilead Sciences Inc2.2M+84.5%$2.7亿5.7%
5RVMD Revolution Medicines Inc1.0M−32.1%$2.0亿4.1%
6ORKA Oruka Therapeutics Inc1.7M+226.9%$1.6亿3.3%
7INSM Insmed Inc1.4M+13787.0%$1.5亿3.1%
8SRRK Scholar Rock Hldg Corp2.4M−31.7%$1.3亿2.8%
9NUVALENT INC Nuvalent Inc1.1M+0.0%$1.3亿2.7%
10VRDN Viridian Therapeutics Inc6.7M+0.1%$1.2亿2.6%
11RLAY Relay Therapeutics Inc6.2M−20.6%$1.2亿2.4%
12PCVX Vaxcyte Inc2.0M+65.6%$1.1亿2.4%
13UTHR United Therapeutics Corp Del188,515+8976.3%$1.0亿2.1%
14ISRG Intuitive Surgical Inc254,809−11.1%$1.0亿2.1%
15REGN Regeneron Pharmaceuticals157,291−43.6%$9808万2.1%
16CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In2.6M−20.1%$9804万2.1%
17BBIO Bridgebio Pharma Inc1.2M+4587.3%$8859万1.9%
18IMCR Immunocore Hldgs Plc2.8M−0.3%$8853万1.9%
19ABT Abbott Laboratories947,115−17.8%$8594万1.8%
20SYK Stryker Corporation268,461+23.6%$8452万1.8%
21MDT Medtronic Plc994,233+3.9%$7778万1.6%
22IONS Ionis Pharmaceuticals Inc972,258−46.5%$7709万1.6%
23ELVN Enliven Therapeutics Inc1.5M−35.8%$7562万1.6%
24VERA Vera Therapeutics Inc1.7M+0.0%$7341万1.5%
25JBIO Jade Biosciences Inc3.1M−12.7%$6795万1.4%
26EW Edwards Lifesciences Corp739,234−11.9%$6687万1.4%
27RARE Ultragenyx Pharmaceutical In2.0M−16.7%$6620万1.4%
28UNH Unitedhealth Group Inc149,127+0.6%$6198万1.3%
29DXCM Dexcom Inc822,489+4.3%$5539万1.2%
30CLDX Celldex Therapeutics Inc New1.2M+0.0%$4465万0.9%
31AVLN Avalyn Pharmaceuticals Inc1.4M—$4444万0.9%
32DMRA Damora Therapeutics Inc1.6M−29.6%$4211万0.9%
33IRON Disc Medicine Inc560,000+21.9%$4096万0.9%
34TMO Thermo Fisher Scientific Inc79,816+23.9%$4002万0.8%
35BSX Boston Scientific Corp887,650−39.5%$3788万0.8%
36LLY Eli Lilly & Co29,882−11.9%$3584万0.8%
37CGON Cg Oncology Inc493,596—$3507万0.7%
38IDXX Idexx Labs Inc61,780−30.7%$3252万0.7%
39RMD Resmed Inc148,195−7.0%$2888万0.6%
40KRYS Krystal Biotech Inc77,530−83.9%$2882万0.6%
41GLUE Monte Rosa Therapeutics Inc1.2M−4.8%$2880万0.6%
42DHR Danaher Corp Del143,844−28.8%$2740万0.6%
43JNJ Johnson & Johnson103,280−13.3%$2623万0.6%
44SPTX Seaport Therapeutics Inc1.1M—$2389万0.5%
45PVLA Palvella Therapeutics Inc Ne155,000—$2369万0.5%
46ALGN Align Technology Inc139,680+0.0%$2356万0.5%
47ANNX Annexon Inc4.1M−20.5%$2341万0.5%
48HUM Humana Inc58,398−9.5%$2320万0.5%
49ELV Elevance Health Inc Formerly56,449+7.5%$2183万0.5%
50TNGX Tango Therapeutics Inc694,182−71.1%$2170万0.5%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。